Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Browse Articles > Previous issues
10 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 29(3); June 2013
Prev issue Next issue
Editorials
Significance of Secreted Protein Acidic and Rich in Cysteine Expression in Colorectal Carcinoma
Young Jin Kim
Ann Coloproctol. 2013;29(3):87-88.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.87
  • 2,688 View
  • 29 Download
PDF
Clinical Significance of the Metastatic Lymph-Node Ratio in Rectal Cancer
Hyoung Chul Park
Ann Coloproctol. 2013;29(3):89-90.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.89
  • 2,573 View
  • 16 Download
  • 1 Citations
PDF

Citations

Citations to this article as recorded by  
  • Lymph Node Ratio Improves TNM and Astler-Coller’s Assessment of Colorectal Cancer Prognosis: an Analysis of 761 Node Positive Cases
    Renato Costi, Filippo Beggi, Valeria Reggiani, Matteo Riccò, Pellegrino Crafa, Melissa Bersanelli, Francesco Tartamella, Vincenzo Violi, Luigi Roncoroni, Leopoldo Sarli
    Journal of Gastrointestinal Surgery.2014; 18(10): 1824.     CrossRef
Individualized Cutoff Value of the Serum Carcinoembryonic Antigen Level According to TNM Stage in Colorectal Cancer
Byung-Kwon Ahn
Ann Coloproctol. 2013;29(3):91-92.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.91
  • 2,715 View
  • 27 Download
  • 4 Citations
PDF

Citations

Citations to this article as recorded by  
  • Development of a novel electrochemical biosensor based on plastic antibodies for detection of STEAP1 biomarker in cancer
    Margarida Carvalho, Rui M. Gomes, Sandra Moreira Rocha, Jorge Barroca-Ferreira, Claudio J. Maia, Lucía Guillade, Miguel A. Correa-Duarte, Luís A. Passarinha, Felismina T.C. Moreira
    Bioelectrochemistry.2023; 152: 108461.     CrossRef
  • CEA-delta could be a biomarker of tumor phenotype, clinical stage, and chemotherapeutic response in rectal cancer with OCT4-positive cancer stem cells
    Ivan David Lozada-Martinez, Maria Paz Bolaño-Romero, Lina Lambis-Anaya, Yamil Liscano, Amileth Suarez-Causado
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Prognostic Significance of Preoperative Serum Carcinoembryonic Antigen Varies with Lymph Node Metastasis Status in Colorectal Cancer
    Jing Jia, MinZhe Li, Wenhao Teng, Lin Wang, Weidong Zang, Jun Xiao, Ying Chen, Dan Zhao
    Journal of Oncology.2021; 2021: 1.     CrossRef
  • Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative
    Zerong Cai, Jian Xiao, Xiaosheng He, Jia Ke, Yifeng Zou, Yufeng Chen, Xianrui Wu, Xiaoling Li, Lei Wang, Jianping Wang, Ping Lan, Xiaojian Wu
    Cancer Biomarkers.2017; 19(2): 161.     CrossRef
Original Articles
Expression of Secreted Protein Acidic and Rich in Cysteine in the Stroma of a Colorectal Carcinoma is Associated With Patient Prognosis
Jeong Yeon Kim, Dongjun Jeong, Tae Sung Ahn, Hyung Ju Kim, Doo San Park, So Yong Park, Sang Byung Bae, Sookyoung Lee, Sung Soo Lee, Moon Soo Lee, Hyun Deuk Cho, Moo Jun Baek
Ann Coloproctol. 2013;29(3):93-99.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.93
  • 5,913 View
  • 29 Download
  • 14 Web of Science
  • 10 Citations
AbstractAbstract PDF
Purpose

Secreted protein acidic and rich in cysteine (SPARC), also known as osteonectin or basement-membrane-40 (BM-40), is a member of a family of matricellular proteins, whose functions are to modulate cell-matrix interactions, growth and angiogenesis in colorectal cancer. In this study, the expression of SPARC was evaluated and its correlations with clinicopathological parameters were investigated.

Methods

The researchers analyzed the expression patterns of SPARC by using immunohistochemistry in 332 cases of colorectal cancer of tissue microarray. The clinicopathological characteristics were defined by using the TNM criteria of the Union for International Cancer Control. Clinicopathological factors such as age, sex, histologic type of the tumor, pathologic tumor stage, TNM stage, and lymphovascular invasion were evaluated according to the SPARC expression.

Results

The hazard ratios expressing SPARC in tumor cells, in the stroma, and in both tumor cells and the stroma were 2.10 (P = 0.036), 3.27 (P = 0.003) and 2.12 (P = 0.038), respectively. Patient survival was decreased in patient expressing SPARC in the stroma, and this result showed statistical significance (P = 0.016).

Conclusion

These findings suggest that SPARC expression in a tumor and in the stroma correlates with disease progression and may be used as a prognostic marker for colorectal cancer.

Citations

Citations to this article as recorded by  
  • CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy
    Keishi Yamashita, Yusuke Kumamoto
    International Journal of Molecular Sciences.2024; 25(11): 6003.     CrossRef
  • Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis
    Xiaoyu Yang, Yunhong Xia, Shuomin Wang, Chen Sun, Raj Kumar Koiri
    PLOS ONE.2022; 17(8): e0273317.     CrossRef
  • SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression
    Qing Nian, Jingwei Li, ZhongYu Han, Qi Liang, Maoyu Liu, Chan Yang, Fernando Rodrigues-Lima, Tao Jiang, Liyun Zhao, Jinhao Zeng, Chi Liu, Jianyou Shi
    Biomedicine & Pharmacotherapy.2022; 153: 113519.     CrossRef
  • Role of SPARC in the epithelial-mesenchymal transition induced by PTHrP in human colon cancer cells
    Pedro Carriere, Natalia Calvo, María Belén Novoa Díaz, Fernanda Lopez-Moncada, Alexander Herrera, María José Torres, Exequiel Alonso, Norberto Ariel Gandini, Graciela Gigola, Hector R. Contreras, Claudia Gentili
    Molecular and Cellular Endocrinology.2021; 530: 111253.     CrossRef
  • Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer
    Andrea Sacchetti, Miriam Teeuwssen, Mathijs Verhagen, Rosalie Joosten, Tong Xu, Roberto Stabile, Berdine van der Steen, Martin M Watson, Alem Gusinac, Won Kyu Kim, Inge Ubink, Harmen JG Van de Werken, Arianna Fumagalli, Madelon Paauwe, Jacco Van Rheenen,
    eLife.2021;[Epub]     CrossRef
  • Secreted protein acidic and rich in cysteine gene variants: Impact on susceptibility and survival of hepatocellular carcinoma patients
    Samar Kamal Darweesh, Rasha Ahmed Abd Alziz, Heba Omar, Dina Sabry, Wael Fathy
    Journal of Gastroenterology and Hepatology.2019; 34(8): 1424.     CrossRef
  • Self‐Targeting, Immune Transparent Plasma Protein Coated Nanocomplex for Noninvasive Photothermal Anticancer Therapy
    Fwu‐Long Mi, Thierry Burnouf, Shih‐Yuan Lu, Yu‐Jen Lu, Kun‐Ying Lu, Yi‐Cheng Ho, Chang‐Yi Kuo, Er‐Yuan Chuang
    Advanced Healthcare Materials.2017;[Epub]     CrossRef
  • SPARC: As a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy
    Neslihan Kurtul, Erdem Arzu Taşdemir, Dilek Ünal, Mustafa İzmirli, Celalettin Eroglu
    Cancer Biomarkers.2017; 18(4): 459.     CrossRef
  • Tumor–stroma ratio is an independent predictor for survival in early cervical carcinoma
    Jing Liu, Juan Liu, Jinsong Li, Yingling Chen, Xiaoling Guan, Xiaojuan Wu, Chunyan Hao, Yanlin Sun, Yan Wang, Xiao Wang
    Gynecologic Oncology.2014; 132(1): 81.     CrossRef
  • Significance of Secreted Protein Acidic and Rich in Cysteine Expression in Colorectal Carcinoma
    Young Jin Kim
    Annals of Coloproctology.2013; 29(3): 87.     CrossRef
Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Rectal Cancer
Wafi Attaallah, Omer Gunal, Manuk Manukyan, Gulden Ozden, Cumhur Yegen
Ann Coloproctol. 2013;29(3):100-105.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.100
  • 4,466 View
  • 38 Download
  • 15 Citations
AbstractAbstract PDF
Purpose

Lymph-node metastasis is the most important predictor of survival in stage III rectal cancer. The number of metastatic lymph nodes may vary depending on the level of specimen dissection and the total number of lymph nodes harvested. The aim of this study was to evaluate whether the lymph node ratio (LNR) is a prognostic parameter for patients with rectal cancer.

Methods

A retrospective review of a database of rectal cancer patients was performed to determine the effect of the LNR on the disease-free survival (DFS) and the overall survival. Of the total 228 patients with rectal cancer, 55 patients with stage III cancer were eligible for analysis. Survival curves were estimated using the Kaplan-Meier method. Cox regression analyses, after adjustments for potential confounders, were used to evaluate the relationship between the LNR and survival.

Results

According to the cutoff point 0.15 (15%), the 2-year DFS was 95.2% among patients with a LNR < 0.15 compared with 67.6% for those with LNR ≥ 0.15 (P = 0.02). In stratified and multivariate analyses adjusted for age, gender, histology and tumor status, a higher LNR was independently associated with worse DFS.

Conclusion

This study showed the prognostic significance of ratio-based staging for rectal cancer and may help in developing better staging systems. LNR 0.15 (15%) was shown to be a cutoff point for determining survival and prognosis in rectal cancer cases.

Citations

Citations to this article as recorded by  
  • Impact of Metastatic Lymph Node Ratio on Survival and Prognosis in Rectal Carcinoma: A Retrospective Cohort Study
    Bahadır Kartal, Mehmet Berksun Tutan
    Cureus.2024;[Epub]     CrossRef
  • Progress in the diagnosis of lymph node metastasis in rectal cancer: a review
    Wei Peng, Huimin Qiao, Linfeng Mo, You Guo
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • The Role of Nonmetastatic Lymph Nodes in the Survival of Colorectal Cancer: A Systematic Review
    Alexander J. Pennings, Brecht A. van der Velden, Maximilian Kloft, Loes F. S. Kooreman, Jos M. P. Kleijnen, Stephanie O. Breukink, Geerard L. Beets, Heike I. Grabsch, Jarno Melenhorst
    Annals of Surgery Open.2023; 4(4): e336.     CrossRef
  • Value of intravoxel incoherent motion for assessment of lymph node status and tumor response after chemoradiation therapy in locally advanced rectal cancer
    Hang Li, Yi Yuan, Xiao-li Chen, Guang-wen Chen, Hao Liu, Yi-Sha Liu, Ming-hui Pang, Si-yun Liu, Hong Pu, Zhen-lin Li
    European Journal of Radiology.2022; 146: 110106.     CrossRef
  • Prognostic Factors of Recurrence and Survival in Operated Patients with Colorectal Cancer
    Alimohammad Bananzadeh, Ali Daneshvar Jahromi, Amirhossein Emami Meybodi, Seyed Mohammad Kazem Tadayon, Mohammad Rezazadehkermani
    Middle East Journal of Digestive Diseases.2022; 14(1): 44.     CrossRef
  • Radiomics Based on T2-Weighted Imaging and Apparent Diffusion Coefficient Images for Preoperative Evaluation of Lymph Node Metastasis in Rectal Cancer Patients
    Chunli Li, Jiandong Yin
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study
    Zeping Huang, Yutong Chen, Wenjun Zhang, Haipeng Liu, Zixian Wang, Youcheng Zhang
    Annals of Surgical Oncology.2020; 27(5): 1480.     CrossRef
  • Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer
    Ji Eun Yoon, Soo Young Lee, Han Duk Kwak, Seung Seop Yeom, Chang Hyun Kim, Jae Kyun Joo, Hyeong Rok Kim, Young Jin Kim
    Annals of Coloproctology.2019; 35(3): 137.     CrossRef
  • Clinical Implications of Lymph Node Metastasis in Colorectal Cancer: Current Status and Future Perspectives
    Hye Jin Kim, Gyu–Seog Choi
    Annals of Coloproctology.2019; 35(3): 109.     CrossRef
  • Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification
    Huan-Jun Li, Yu-Tong Chen, Shu-Qiang Yuan
    Medicine.2018; 97(34): e12094.     CrossRef
  • A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma
    M Elshaer, G Gravante, M Kosmin, A Riaz, A Al-Bahrani
    The Annals of The Royal College of Surgeons of England.2017; 99(2): 101.     CrossRef
  • Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma
    Mohamad Adel, Chung-Kan Tsao, Fu-Chan Wei, Huei-Tzu Chien, Chih-Hsiung Lai, Chun-Ta Liao, Hung-Ming Wang, Kang-Hsing Fan, Chung-Jan Kang, Joseph Tung-Chieh Chang, Shiang-Fu Huang
    Medicine.2016; 95(14): e3149.     CrossRef
  • Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer
    Wafi Attaallah, Kivilcim Uprak, Omer Gunal, Cumhur Yegen
    Indian Journal of Surgical Oncology.2016; 7(1): 67.     CrossRef
  • Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research
    S G Patel, M Amit, T C Yen, C T Liao, P Chaturvedi, J P Agarwal, L P Kowalski, A Ebrahimi, J R Clark, C R Cernea, S J Brandao, M Kreppel, J Zöller, D Fliss, E Fridman, G Bachar, T Shpitzer, V A Bolzoni, P R Patel, S Jonnalagadda, K T Robbins, J P Shah, Z
    British Journal of Cancer.2013; 109(8): 2087.     CrossRef
  • Clinical Significance of the Metastatic Lymph-Node Ratio in Rectal Cancer
    Hyoung Chul Park
    Annals of Coloproctology.2013; 29(3): 89.     CrossRef
Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker
Byeong Geon Jeon, Rumi Shin, Jung Kee Chung, In Mok Jung, Seung Chul Heo
Ann Coloproctol. 2013;29(3):106-114.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.106
  • 4,431 View
  • 37 Download
  • 18 Citations
AbstractAbstract PDF
Purpose

Carcinoembryonic antigen (CEA) is an important prognostic marker in colorectal cancer (CRC). However, in some stages, it does not work. We performed this study to find a way in which preoperative CEA could be used as a constant prognostic marker in harmony with the TNM staging system.

Methods

Preoperative CEA levels and recurrences in CRC were surveyed. The distribution of CEA levels and the recurrences in each TNM stage of CRC were analyzed. An optimal cutoff value for each TNM stage was calculated and tested for validity as a prognostic marker within the TNM staging system.

Results

The conventional cutoff value of CEA (5 ng/mL) was an independent prognostic factor on the whole. However, when evaluated in subgroups, it was not a prognostic factor in stage I or stage III of N2. A subgroup analysis according to TNM stage revealed different CEA distributions and recurrence rates corresponding to different CEA ranges. The mean CEA levels were higher in advanced stages. In addition, the recurrence rates of corresponding CEA ranges were higher in advanced stages. Optimal cutoff values from the receiver operating characteristic curves were 7.4, 5.5, and 4.5 ng/mL for TNM stage I, II, and III, respectively. Those for N0, N1, and N2 stages were 5.5, 4.8, and 3.5 ng/mL, respectively. The 5-year disease-free survivals were significantly different according to these cutoff values for each TNM and N stage. The multivariate analysis confirmed the new cutoff values to be more efficient in discriminating the prognosis in the subgroups of the TNM stages.

Conclusion

Individualized cutoff values of the preoperative CEA level are a more practical prognostic marker following and in harmony with the TNM staging system.

Citations

Citations to this article as recorded by  
  • Cell-free circulating ALU repeats in serum have a prognostic value for colorectal cancer patients
    Isabel Anzinger, Dorothea Nagel, Enrico N. De Toni, Andrea Ofner, Alexander B. Philipp, Lesca M. Holdt, Daniel Teupser, Frank T. Kolligs, Andreas Herbst
    Cancer Biomarkers.2023; 37(4): 237.     CrossRef
  • Prognostic value of preoperative carcinoembryonic antigen and D-dimer concentrations in patients undergoing curative resection for colorectal cancer
    Yasutomo Ojima, Masao Harano, Daisuke Sumitani, Masanori Yoshimitsu, Masazumi Okajima
    Surgery Today.2021; 51(7): 1108.     CrossRef
  • Incidence of and Risk Factors for Gastroepiploic Lymph Node Involvement in Patients with Cancer of the Transverse Colon Including the Hepatic Flexure
    Xiaojie Wang, Shenghui Huang, Xingrong Lu, Ying Huang, Pan Chi
    World Journal of Surgery.2021; 45(5): 1514.     CrossRef
  • Diagnostic accuracy of follow‐up tests for detecting colorectal cancer recurrences in primary care: A systematic review and meta‐analysis
    Geertje B. Liemburg, Daan Brandenbarg, Marjolein Y. Berger, Saskia F.A. Duijts, Gea A. Holtman, Geertruida H. Bock, Joke C. Korevaar, Annette J. Berendsen
    European Journal of Cancer Care.2021;[Epub]     CrossRef
  • Serum carcinoembryonic antigen pre‐operative level in colorectal cancer: revisiting risk stratification
    Cristiana Iacuzzo, Paola Germani, Marina Troian, Tommaso Cipolat Mis, Fabiola Giudici, Edoardo Osenda, Marina Bortul, Nicolò de Manzini
    ANZ Journal of Surgery.2021;[Epub]     CrossRef
  • The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres
    Ali Riaz Baqar, Simon Wilkins, Margaret Staples, Chun Hin Angus Lee, Karen Oliva, Paul McMurrick
    International Journal of Surgery.2019; 64: 10.     CrossRef
  • Comparison of Four Automated Carcinoembryonic Antigen Immunoassays: ADVIA Centaur XP, ARCHITECT I2000sr, Elecsys E170, and Unicel Dxi800
    Joonhong Park, Seungok Lee, Yeongsic Kim, Aeran Choi, Hyeyoung Lee, Jihyang Lim, Yonggoo Kim, Kyungja Han, Eun-jee Oh
    Annals of Laboratory Medicine.2018; 38(4): 355.     CrossRef
  • Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
    Julia Bergheim, Alexander Semaan, Heidrun Gevensleben, Susanne Groening, Andreas Knoblich, Jörn Dietrich, Julia Weber, Jörg C. Kalff, Friedrich Bootz, Glen Kristiansen, Dimo Dietrich
    British Journal of Cancer.2018; 118(9): 1217.     CrossRef
  • Pre‐operative carcinoembryonic antigen predicts survival following colorectal cancer surgery with curative intent
    Ashok Gunawardene, Peter Larsen, Ali Shekouh, Elizabeth Dennett
    ANZ Journal of Surgery.2018; 88(12): 1311.     CrossRef
  • Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative
    Zerong Cai, Jian Xiao, Xiaosheng He, Jia Ke, Yifeng Zou, Yufeng Chen, Xianrui Wu, Xiaoling Li, Lei Wang, Jianping Wang, Ping Lan, Xiaojian Wu
    Cancer Biomarkers.2017; 19(2): 161.     CrossRef
  • A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer
    Hao Wang, Ai-Min Meng, Sheng-Hua Li, Xiao-Liang Zhou
    Molecular Medicine Reports.2017; 16(1): 625.     CrossRef
  • Valor pronóstico pretratamiento del antígeno carcinoembrionario en el cáncer colorrectal operado. ¿Es útil en todos los estadios del tumor?
    Ana Borda, Carlos Prieto, Javier Jiménez, Juan Vila, José Manuel Zozaya, Fernando Borda
    Gastroenterología y Hepatología.2016; 39(3): 191.     CrossRef
  • Prognostic value of preoperative carcinoembryogenic antigen: Is it useful in all stages of colorectal cancer?
    Ana Borda, Carlos Prieto, Javier Jiménez, Juan Vila, José Manuel Zozaya, Fernando Borda
    Gastroenterología y Hepatología (English Edition).2016; 39(3): 191.     CrossRef
  • Analysis of colorectal cancer glyco‐secretome identifies laminin β‐1 (LAMB1) as a potential serological biomarker for colorectal cancer
    Qifeng Lin, Hannah S.R. Lim, Hui Ling Lin, Hwee Tong Tan, Teck Kwang Lim, Wai Kit Cheong, Peh Yean Cheah, Choong Leong Tang, Pierce K. H. Chow, Maxey C. M. Chung
    PROTEOMICS.2015; 15(22): 3905.     CrossRef
  • Preoperative Carcinoembryonic Antigen and Prognosis of Colorectal Cancer. An Independent Prognostic Factor Still Reliable
    Giovanni Li Destri, Antonio Salvatore Rubino, Rosalia Latino, Fabio Giannone, Raffaele Lanteri, Beniamino Scilletta, Antonio Di Cataldo
    International Surgery.2015; 100(4): 617.     CrossRef
  • Carcinoembryonic antigen levels in colorectal cancer: Are we too preoccupied?
    G Aggarwal, MK Roy, S Banerjee
    Indian Journal of Cancer.2014; 51(4): 452.     CrossRef
  • Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers
    Haitham A Badr, Dina MM AlSadek, Ashraf A Darwish, Abdelaleim I ElSayed, Bakhytzhan O Bekmanov, Elmira M Khussainova, Xueji Zhang, William CS Cho, Leyla B Djansugurova, Chen-Zhong Li
    Expert Review of Proteomics.2014; 11(2): 227.     CrossRef
  • Individualized Cutoff Value of the Serum Carcinoembryonic Antigen Level According to TNM Stage in Colorectal Cancer
    Byung-Kwon Ahn
    Annals of Coloproctology.2013; 29(3): 91.     CrossRef
Prognostic Significance of the Decreased Rate of Perioperative Serum Carcinoembryonic Antigen Level in the Patients With Colon Cancer After a Curative Resection
Tae Doo Jung, Jong Han Yoo, Min Jae Lee, Ha Kyung Park, Jae Ho Shin, Min Sung An, Tae Kwun Ha, Kwang Hee Kim, Ki Beom Bae, Tae Hyeon Kim, Chang Soo Choi, Min Kyung Oh, Kwan Hee Hong
Ann Coloproctol. 2013;29(3):115-122.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.115
  • 2,959 View
  • 22 Download
  • 3 Citations
AbstractAbstract PDF
Purpose

The serum level of carcinoembryonic antigen (CEA) is a clinical prognostic factor in the follow-up evaluation of patients with colon cancer. We aimed to evaluate the prognostic significance of the rate of decrease of the perioperative serum CEA level in patients with colon cancer after a curative resection.

Methods

A total of 605 patients who underwent a curative resection for colon cancer between January 2000 and December 2007 were enrolled retrospectively. The rate of decrease was calculated using the following equation: ([preoperative CEA - postoperative CEA]/[preoperative CEA] ×100).

Results

In the group with a preoperative serum CEA level of >5 ng/mL, the normalized group with a postoperative serum CEA level of ≤5 ng/mL showed a better overall survival (OS) rate and disease-free survival (DFS) rate than those of the non-normalized group (P ≤ 0.0001). The "cutoff values" of the rate of decrease in the perioperative serum CEA that determined the OS and the DFS were 48.9% and 50.8%, respectively. In the multivariate analysis of preoperative serum CEA levels >5 ng/mL, the prognostic factors for the OS and the DFS were the cutoff value (P < 0.0001) and the pN stage (P < 0.0001).

Conclusion

A rate of decrease of more than 50% in the perioperative serum CEA level, as well as the normalization of the postoperative serum CEA level, may be useful factors for determining a prognosis for colon cancer patients with high preoperative CEA levels.

Citations

Citations to this article as recorded by  
  • Metastasis of colorectal adenocarcinoma to the mandible
    Kushal CHATTERJEE, Aritra CHATTERJEE, Debarati BHOWMICK, Hrishikesh KUMAR, Arif HOSSAIN, Debabrata GAYEN
    European Journal of Oral and Maxillofacial Surgery.2021;[Epub]     CrossRef
  • Perioperative Serum Carcinoembryonic Antigen Ratio Is a Prognostic Indicator in Patients With Stage II Colorectal Cancer
    Jinsun Woo, Jungbin Kim, Inseok Park, Hyunjin Cho, Geumhee Gwak, Keun Ho Yang, Byung-Noe Bae, Ki Hwan Kim
    Annals of Coloproctology.2018; 34(1): 4.     CrossRef
  • Clinicopathologic features and oncologic outcomes of colorectal cancer patients with extremely high carcinoembryonic antigen
    Soo Young Lee, Jeong Seon Jo, Hun Jin Kim, Chang Hyun Kim, Jae-Kyun Ju, Young Jin Kim, Hyeong Rok Kim
    International Journal of Colorectal Disease.2015; 30(1): 63.     CrossRef
Case Reports
Primary Multiple Mesenteric Liposarcoma of the Transverse Mesocolon
Sandeep Sachidananda, Arunkumar Krishnan, Raja Ramesh, Sivaprakasam Kuppurao
Ann Coloproctol. 2013;29(3):123-125.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.123
  • 3,187 View
  • 28 Download
  • 6 Citations
AbstractAbstract PDF

Liposarcomas are common tumors arising in the retroperitoneum. However, a primary mesenteric liposarcoma is a rare entity and less than 50 cases have been reported so far. Further, a liposarcoma arising in the transverse mesocolon is very unusual, and cases of multiple primary tumors arising from the transverse mesocolon are extremely rare. We want to report a case of a multiple primary mesenteric liposarcoma arising from the transverse mesocolon in a 63-year-old female who was successfully treated by surgery. Because a primary mesenteric liposarcoma is a rare entity, it should be considered with the differential diagnosis of an abdominal mesenchymal tumor. It can be diagnosed preoperatively by using contrast enhanced computed tomography and magnetic resonance imaging. The treatment for such a liposarcoma is surgical resection with sufficient surgical margin; the role of adjuvant therapy has yet to be defined.

Citations

Citations to this article as recorded by  
  • Dedifferentiated liposarcoma of small bowel mesentery: a rare case report
    Sunil Dhakal, Ijendra Prajapati
    Journal of Surgical Case Reports.2022;[Epub]     CrossRef
  • Giant mesenteric myxoid liposarcoma: Challenges of diagnosis and treatment
    Rania Mokfi, Farah Boutaggount, Meryem Maskrout, Ghizlane Rais
    Radiology Case Reports.2022; 17(11): 4227.     CrossRef
  • Dedifferentiated liposarcoma in the abdominal cavity: a case report
    Marina Kuroda, Reiko Yamada, Takamitsu Tanaka, Junya Tsuboi, Misaki Nakamura, Masaki Katsurahara, Yasuhiko Hamada, Kyosuke Tanaka, Noriyuki Horiki, Hayato Nakagawa
    Clinical Journal of Gastroenterology.2022; 15(6): 1094.     CrossRef
  • The colorectal surgeon's liposarcoma
    Alfred Wong, Han‐Kuang Chen, Michael Levitt
    ANZ Journal of Surgery.2018;[Epub]     CrossRef
  • A mesenteric solid tumor with unusual features in a young male: A case report
    Yoshitoshi Ichikawa, Tamaki Maeda, Gaku Mizojiri, Satoshi Ishikawa, Takaomi Hagi, Kimiaki Hattori, Hiroshi Oka
    Molecular and Clinical Oncology.2017; 7(3): 355.     CrossRef
  • Multiple mesenteric well-differentiated liposarcoma complicated by purulent inflammation: A case report
    WEI GAO, HUAIZHOU WANG, JINYU LIU, FUJIANG WANG, JIANJUN DONG, JUNZU GENG
    Oncology Letters.2015; 9(3): 1333.     CrossRef
Intramural Recurrence Without Mucosal Lesions After an Endoscopic Mucosal Resection for Early Colorectal Cancer
Min Sung Kim, Nam Kyu Kim, Ji Hye Park
Ann Coloproctol. 2013;29(3):126-129.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.126
  • 3,326 View
  • 30 Download
  • 7 Citations
AbstractAbstract PDF

Advances in endoscopic instruments and techniques have enabled increased detection and removal of early colorectal cancer (ECC), which is defined as a tumor whose invasion is limited to the mucosa or submucosa. Some cases can be treated by endoscopic mucosal resection (EMR). However, local recurrence frequently occurs after an EMR for ECC. The recurrence pattern is usually intramural recurrence with a mucosal lesion at the EMR's site. We report the cases of two patients with intramural recurrence without mucosal lesions after an EMR for ECC. These cases indicate that a local recurrence after an EMR for ECC can appear as an intramural recurrence without mucosal lesions at a previous EMR site or another site, although this presentation is very unusual.

Citations

Citations to this article as recorded by  
  • Multidisciplinary Treatment Strategy for Early Colon Cancer: A Review-An English Version
    Gyung Mo Son, Su Bum Park, Tae Un Kim, Byung-Soo Park, In Young Lee, Joo-Young Na, Dong Hoon Shin, Sang Bo Oh, Sung Hwan Cho, Hyun Sung Kim, Hyung Wook Kim
    Journal of the Anus, Rectum and Colon.2022; 6(4): 203.     CrossRef
  • Growth-inhibition of S180 residual-tumor by combination of cyclophosphamide and chitosan oligosaccharides in vivo
    Xingchen Zhai, Shoujun Yuan, Xin Yang, Pan Zou, Yong Shao, A.M. Abd El-Aty, Ahmet Hacımüftüoğlu, Jing Wang
    Life Sciences.2018; 202: 21.     CrossRef
  • Handling and Pathology Reporting of Gastrointestinal Endoscopic Mucosal Resection
    Bita Geramizadeh, David A. Owen
    Middle East Journal of Digestive Diseases.2017; 9(1): 5.     CrossRef
  • Feasibility of mesorectal vascular invasion in predicting early distant metastasis in patients with stage T3 rectal cancer based on rectal MRI
    Young Chul Kim, Jai Keun Kim, Myeong-Jin Kim, Jei Hee Lee, Young Bae Kim, Sung Jae Shin
    European Radiology.2016; 26(2): 297.     CrossRef
  • Antitumor Effects of Orally and Intraperitoneally Administered Chitosan Oligosaccharides (COSs) on S180‐Bearing/Residual Mouse
    Pan Zou, Xin Yang, Yanxin Zhang, Pengfei Du, Shoujun Yuan, Dexuan Yang, Jing Wang
    Journal of Food Science.2016;[Epub]     CrossRef
  • Re-evaluation of indications and outcomes of endoscopic excision procedures for colorectal tumors: a review
    S. Cai, Y. Zhong, P. Zhou, J. Xu, L. Yao
    Gastroenterology Report.2014; 2(1): 27.     CrossRef
  • Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors
    Yinghong An, Linna Li, Dexuan Yang, Na Jia, Chengwang Xu, Qiong Wang, Shanshan Wang, Shoujun Yuan
    Anti-Cancer Drugs.2014; 25(8): 857.     CrossRef
Mucosal Schwann-Cell Hamartoma Diagnosed by Using an Endoscopic Snare Polypectomy
Myoung Nam Bae, Jung Eun Lee, Sang Mook Bae, Eun Young Kim, Eun Ok Kim, Sung Hoon Jung, Jung Hwan Oh, Ki Ok Min
Ann Coloproctol. 2013;29(3):130-134.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.130
  • 5,404 View
  • 88 Download
  • 13 Citations
AbstractAbstract PDF

Colorectal polyps of mesenchymal origin are a rare group of colorectal disorders. A "mucosal Schwann-cell hamartoma," which is one type of polypoid lesion that originates from the mesenchyme, is a newly-proposed disease entity to be distinguished from the neurofibromas found in type-1 neurofibromatosis. This lesion is composed of pure Schwann-cell proliferation in the lamina propria and shows diffuse immunoreactivity for the S-100 protein. We report a case of a polypoid lesion of the colon with the features of this recently-proposed disease entity.

Citations

Citations to this article as recorded by  
  • An Unusual Case of Schwann Cell Hamartoma in Colon
    Sanna Salam, Hazem Abosheaishaa, Muhammad Haseeb ul Rasool, Nimra Qasim, Ghullamullah Shahzad
    Cureus.2023;[Epub]     CrossRef
  • A Rare Case of Schwann Cell Hamartoma in the Duodenum
    Kasopefoluwa Y. Oguntuyo, Lauren L. Donnangelo, Guangjing Zhu, Stephen Ward, Abhik Bhattacharaya
    ACG Case Reports Journal.2022; 9(11): e00894.     CrossRef
  • Multiple non-polypoid mucosal Schwann cell hamartomas presenting as edematous and submucosal tumor-like lesions: a case report
    Takeshi Okamoto, Takaaki Yoshimoto, Katsuyuki Fukuda
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Mucosal Schwann Cell Hamartoma of the Gall Bladder
    Kanika Sharma, Anjan Kumar Dhua, Prabudh Goel, Vishesh Jain, Devendra Kumar Yadav, Prashant Ramteke
    Journal of Indian Association of Pediatric Surgeons.2021; 26(3): 182.     CrossRef
  • Mucosal Schwann Cell Hamartoma in sigmoid colon – A rare case report and review of literature
    Xiuyan Feng, Hongzhi Xu, Nestor Dela Cruz
    Human Pathology: Case Reports.2020; 19: 200337.     CrossRef
  • Mucosal Schwann cell hamartoma of the gastroesophageal junction: A series of 6 cases and comparison with colorectal counterpart
    Yuan Li, Pouneh Beizai, John W. Russell, Lindsey Westbrook, Arash Nowain, Hanlin L. Wang
    Annals of Diagnostic Pathology.2020; 47: 151531.     CrossRef
  • Colonic mucosal Schwann cell hamartoma
    María Vaamonde‐Lorenzo, Kepa Elorriaga, Isabel Montalvo, Luis Bujanda
    Journal of Digestive Diseases.2020; 21(8): 475.     CrossRef
  • Mucosal Schwann Cell Hamartoma Presenting as Diffuse Fine Nodularities
    Han Beol Jang, Jong Ok Kim, Sang-Bum Kang
    The Korean Journal of Gastroenterology.2020; 76(3): 171.     CrossRef
  • A case of Schwann cell hamartoma of the tongue
    Saya TAKIKAWA, Shigeo TANAKA, Masamichi KOMIYA, Masaaki SUEMITSU, Tadahiko UTSUNOMIYA, Kayo KUYAMA
    Japanese Journal of Oral and Maxillofacial Surgery.2020; 66(12): 601.     CrossRef
  • Hamartoma de células de Schwann mucoso: revisión de una entidad descrita recientemente
    Francisco García-Molina, José Antonio Ruíz-Macia, Joaquin Sola
    Revista Española de Patología.2018; 51(1): 49.     CrossRef
  • Mucosal Schwann cell hamartoma of gall bladder: a novel observation
    Gaurav Khanna, Shouriyo Ghosh, Adarsh Barwad, Rajni Yadav, Prasenjit Das
    Pathology.2018; 50(4): 480.     CrossRef
  • Mucosal Schwann Cell Hamartoma in Colorectal Mucosa: A Rare Benign Lesion That Resembles Gastrointestinal Neuroma
    Jiheun Han, Yosep Chong, Tae-Jung Kim, Eun Jung Lee, Chang Suk Kang
    Journal of Pathology and Translational Medicine.2017; 51(2): 187.     CrossRef
  • Synchronous mucosal Schwann-cell hamartomas in a young adult suggestive of mucosal Schwann-cell harmatomatosis: a case report
    Jeong Mo Bae, Joon Young Lee, Junhun Cho, Sang Ah Lim, Gyeong Hoon Kang
    BMC Gastroenterology.2015;[Epub]     CrossRef

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP